Drugs / AVIHepC1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07237282 | Aug 2026 → Jan 2027 expected | hepatitis C virus infection | University of Alberta | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AVIHepC1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07237282 ↗ |
| Modality | Vaccine | “experimental (investigational) vaccine against HCV” NCT07237282 ↗ |
| Route | Intramuscular | “Intramuscular injection administered at 0, 4, and 24 weeks.” NCT07237282 ↗ |